KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) EPS (Basic): 2018-2025

Historic EPS (Basic) for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to $0.38.

  • BioNTech SE's EPS (Basic) fell 31.08% to $0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.15, marking a year-over-year decrease of 185.46%. This contributed to the annual value of -$2.96 for FY2024, which is 171.09% down from last year.
  • Per BioNTech SE's latest filing, its EPS (Basic) stood at $0.38 for Q3 2025, which was up 119.26% from -$1.97 recorded in Q2 2025.
  • BioNTech SE's 5-year EPS (Basic) high stood at $34.43 for Q3 2021, and its period low was -$3.64 during Q2 2024.
  • In the last 3 years, BioNTech SE's EPS (Basic) had a median value of $0.38 in 2025 and averaged -$0.03.
  • Per our database at Business Quant, BioNTech SE's EPS (Basic) spiked by 115,179,921.14% in 2022 and then slumped by 139.16% in 2024.
  • Quarterly analysis of 5 years shows BioNTech SE's EPS (Basic) stood at $0.00 in 2021, then soared by 115,179,921.14% to $17.07 in 2022, then slumped by 76.97% to $3.93 in 2023, then plummeted by 61.12% to $1.53 in 2024, then plummeted by 31.08% to $0.38 in 2025.
  • Its EPS (Basic) was $0.38 in Q3 2025, compared to -$1.97 in Q2 2025 and -$2.08 in Q1 2025.